| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgery | 27 | 2022 | 157 | 9.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 51 | 2024 | 427 | 6.450 |
Why?
|
| Cardiac Surgical Procedures | 38 | 2023 | 1099 | 4.620 |
Why?
|
| Thoracic Surgical Procedures | 12 | 2022 | 92 | 3.600 |
Why?
|
| Aortic Aneurysm, Thoracic | 25 | 2024 | 663 | 3.450 |
Why?
|
| Surgeons | 11 | 2023 | 248 | 3.170 |
Why?
|
| Coronary Artery Bypass | 30 | 2024 | 486 | 3.060 |
Why?
|
| Heart Valve Diseases | 20 | 2022 | 166 | 3.050 |
Why?
|
| Atrial Fibrillation | 28 | 2023 | 624 | 2.890 |
Why?
|
| Blood Vessel Prosthesis Implantation | 22 | 2024 | 795 | 2.710 |
Why?
|
| Aortic Valve | 28 | 2024 | 432 | 2.520 |
Why?
|
| Aortic Valve Stenosis | 22 | 2024 | 329 | 2.450 |
Why?
|
| Societies, Medical | 15 | 2024 | 678 | 2.430 |
Why?
|
| Mitral Valve | 21 | 2022 | 246 | 2.330 |
Why?
|
| Cardiac Catheterization | 24 | 2015 | 631 | 2.150 |
Why?
|
| Heart Valve Prosthesis | 16 | 2024 | 293 | 2.140 |
Why?
|
| Bioprosthesis | 14 | 2023 | 111 | 2.010 |
Why?
|
| Ventricular Function, Right | 11 | 2012 | 112 | 1.990 |
Why?
|
| Aorta, Thoracic | 16 | 2024 | 519 | 1.940 |
Why?
|
| Education, Medical, Graduate | 10 | 2021 | 507 | 1.910 |
Why?
|
| Mitral Valve Insufficiency | 11 | 2022 | 156 | 1.800 |
Why?
|
| Aortic Aneurysm | 13 | 2021 | 224 | 1.760 |
Why?
|
| Myocardial Revascularization | 9 | 2021 | 96 | 1.720 |
Why?
|
| Marfan Syndrome | 4 | 2019 | 137 | 1.700 |
Why?
|
| Specialties, Surgical | 4 | 2022 | 79 | 1.660 |
Why?
|
| Internship and Residency | 8 | 2022 | 1158 | 1.640 |
Why?
|
| Coronary Artery Disease | 11 | 2024 | 746 | 1.640 |
Why?
|
| Postoperative Complications | 39 | 2024 | 3014 | 1.620 |
Why?
|
| Certification | 4 | 2022 | 67 | 1.580 |
Why?
|
| Humans | 239 | 2024 | 123232 | 1.540 |
Why?
|
| Hypertension, Pulmonary | 8 | 2015 | 430 | 1.520 |
Why?
|
| Clinical Competence | 17 | 2023 | 973 | 1.510 |
Why?
|
| Myocardial Ischemia | 9 | 2023 | 332 | 1.440 |
Why?
|
| Treatment Outcome | 82 | 2024 | 12141 | 1.360 |
Why?
|
| Catheter Ablation | 18 | 2021 | 233 | 1.360 |
Why?
|
| Cardiology | 10 | 2021 | 472 | 1.350 |
Why?
|
| Atrial Function, Right | 6 | 2012 | 9 | 1.320 |
Why?
|
| Aortic Diseases | 12 | 2024 | 196 | 1.300 |
Why?
|
| Reoperation | 14 | 2022 | 819 | 1.200 |
Why?
|
| Aortic Valve Insufficiency | 7 | 2022 | 138 | 1.180 |
Why?
|
| Endovascular Procedures | 7 | 2024 | 729 | 1.180 |
Why?
|
| Ventricular Function, Left | 17 | 2021 | 494 | 1.170 |
Why?
|
| Vascular Surgical Procedures | 12 | 2024 | 565 | 1.140 |
Why?
|
| Endocarditis | 6 | 2024 | 101 | 1.120 |
Why?
|
| Heart Diseases | 10 | 2023 | 482 | 1.110 |
Why?
|
| History, 20th Century | 10 | 2017 | 383 | 1.060 |
Why?
|
| Retrospective Studies | 81 | 2024 | 16033 | 1.040 |
Why?
|
| Ventricular Pressure | 5 | 2012 | 43 | 1.020 |
Why?
|
| Hemodynamics | 15 | 2018 | 845 | 1.020 |
Why?
|
| Specialty Boards | 2 | 2022 | 19 | 0.980 |
Why?
|
| Aged | 97 | 2024 | 19098 | 0.960 |
Why?
|
| Periodicals as Topic | 3 | 2017 | 195 | 0.960 |
Why?
|
| Risk Factors | 47 | 2024 | 10015 | 0.920 |
Why?
|
| Male | 142 | 2024 | 60122 | 0.920 |
Why?
|
| Risk Assessment | 35 | 2024 | 3316 | 0.910 |
Why?
|
| Ventricular Dysfunction, Right | 4 | 2012 | 78 | 0.900 |
Why?
|
| Aged, 80 and over | 51 | 2020 | 6372 | 0.890 |
Why?
|
| Middle Aged | 97 | 2024 | 26017 | 0.890 |
Why?
|
| Heart Ventricles | 9 | 2021 | 759 | 0.860 |
Why?
|
| Female | 138 | 2024 | 65551 | 0.850 |
Why?
|
| Heart-Assist Devices | 12 | 2021 | 1026 | 0.830 |
Why?
|
| Jehovah's Witnesses | 1 | 2022 | 15 | 0.830 |
Why?
|
| History, 21st Century | 7 | 2017 | 272 | 0.820 |
Why?
|
| United States | 30 | 2024 | 10638 | 0.810 |
Why?
|
| Blood Vessel Prosthesis | 11 | 2020 | 533 | 0.790 |
Why?
|
| Transcatheter Aortic Valve Replacement | 6 | 2024 | 194 | 0.790 |
Why?
|
| Laser Therapy | 5 | 2006 | 246 | 0.790 |
Why?
|
| Dogs | 23 | 2012 | 765 | 0.780 |
Why?
|
| Missouri | 12 | 2018 | 36 | 0.780 |
Why?
|
| Heart Atria | 9 | 2020 | 311 | 0.760 |
Why?
|
| Mitral Valve Annuloplasty | 3 | 2021 | 15 | 0.760 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2023 | 228 | 0.740 |
Why?
|
| Arterial Pressure | 2 | 2019 | 104 | 0.740 |
Why?
|
| Time Factors | 37 | 2024 | 6221 | 0.730 |
Why?
|
| Heart Transplantation | 11 | 2023 | 854 | 0.720 |
Why?
|
| Career Choice | 2 | 2022 | 143 | 0.710 |
Why?
|
| Heart | 6 | 2022 | 723 | 0.700 |
Why?
|
| Coronavirus | 1 | 2020 | 24 | 0.700 |
Why?
|
| Sexual Harassment | 1 | 2019 | 18 | 0.680 |
Why?
|
| Stents | 9 | 2020 | 872 | 0.680 |
Why?
|
| Hemofiltration | 1 | 2019 | 13 | 0.660 |
Why?
|
| Learning Curve | 4 | 2021 | 53 | 0.650 |
Why?
|
| Clinical Decision-Making | 4 | 2021 | 265 | 0.630 |
Why?
|
| Minority Groups | 1 | 2020 | 253 | 0.620 |
Why?
|
| Anemia | 1 | 2022 | 340 | 0.620 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2018 | 9 | 0.610 |
Why?
|
| Survival Analysis | 19 | 2018 | 1472 | 0.600 |
Why?
|
| Follow-Up Studies | 30 | 2020 | 5049 | 0.590 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 360 | 0.590 |
Why?
|
| White Matter | 1 | 2020 | 181 | 0.590 |
Why?
|
| Educational Measurement | 3 | 2015 | 324 | 0.590 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 376 | 0.590 |
Why?
|
| Heart Failure | 9 | 2021 | 2127 | 0.580 |
Why?
|
| Stroke | 4 | 2023 | 958 | 0.570 |
Why?
|
| Patient Care Team | 11 | 2021 | 548 | 0.570 |
Why?
|
| Forecasting | 2 | 2018 | 354 | 0.570 |
Why?
|
| Hospitals | 7 | 2023 | 396 | 0.550 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 300 | 0.540 |
Why?
|
| Adult | 57 | 2022 | 29072 | 0.540 |
Why?
|
| Pandemics | 3 | 2021 | 1101 | 0.530 |
Why?
|
| Patient Readmission | 5 | 2024 | 366 | 0.510 |
Why?
|
| Survival Rate | 21 | 2021 | 1996 | 0.510 |
Why?
|
| Consensus | 6 | 2024 | 612 | 0.500 |
Why?
|
| Vascular Neoplasms | 2 | 2014 | 32 | 0.500 |
Why?
|
| Task Performance and Analysis | 2 | 2015 | 95 | 0.500 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 613 | 0.500 |
Why?
|
| Aortic Rupture | 5 | 2012 | 118 | 0.500 |
Why?
|
| Prosthesis-Related Infections | 4 | 2024 | 176 | 0.490 |
Why?
|
| Positron Emission Tomography Computed Tomography | 3 | 2024 | 77 | 0.490 |
Why?
|
| Multivariate Analysis | 18 | 2016 | 1414 | 0.480 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2024 | 135 | 0.480 |
Why?
|
| Dissection | 2 | 2024 | 52 | 0.460 |
Why?
|
| Brain Injuries | 1 | 2020 | 762 | 0.450 |
Why?
|
| Radial Artery | 4 | 2012 | 26 | 0.450 |
Why?
|
| Cardiac Output | 5 | 2012 | 169 | 0.450 |
Why?
|
| Patient Selection | 10 | 2021 | 685 | 0.450 |
Why?
|
| Curriculum | 2 | 2018 | 719 | 0.440 |
Why?
|
| Cryosurgery | 4 | 2017 | 46 | 0.440 |
Why?
|
| Sternotomy | 1 | 2014 | 42 | 0.440 |
Why?
|
| Severity of Illness Index | 12 | 2023 | 2839 | 0.440 |
Why?
|
| Radiopharmaceuticals | 2 | 2024 | 155 | 0.430 |
Why?
|
| Sarcoma | 2 | 2014 | 194 | 0.430 |
Why?
|
| Endocarditis, Bacterial | 3 | 2007 | 129 | 0.430 |
Why?
|
| Thoracotomy | 1 | 2014 | 108 | 0.420 |
Why?
|
| Coronary Disease | 7 | 2017 | 637 | 0.420 |
Why?
|
| Myocardial Contraction | 9 | 2012 | 260 | 0.420 |
Why?
|
| Ostomy | 1 | 2012 | 11 | 0.420 |
Why?
|
| Military Medicine | 1 | 2013 | 47 | 0.410 |
Why?
|
| Anticoagulants | 5 | 2023 | 581 | 0.410 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 169 | 0.410 |
Why?
|
| Pulmonary Valve | 5 | 2015 | 94 | 0.410 |
Why?
|
| Vena Cava, Superior | 1 | 2012 | 55 | 0.410 |
Why?
|
| Hypertension | 4 | 2012 | 1287 | 0.390 |
Why?
|
| Faculty, Medical | 1 | 2014 | 266 | 0.380 |
Why?
|
| Angioplasty | 2 | 2009 | 85 | 0.380 |
Why?
|
| Health Status Indicators | 2 | 2012 | 120 | 0.380 |
Why?
|
| Attitude of Health Personnel | 4 | 2021 | 641 | 0.370 |
Why?
|
| Device Removal | 3 | 2008 | 222 | 0.370 |
Why?
|
| Coronary Circulation | 4 | 2009 | 209 | 0.360 |
Why?
|
| Physicians, Women | 2 | 2022 | 46 | 0.360 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 233 | 0.360 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2013 | 254 | 0.360 |
Why?
|
| Coronary Vessels | 1 | 2014 | 526 | 0.360 |
Why?
|
| Combined Modality Therapy | 8 | 2021 | 1239 | 0.350 |
Why?
|
| Kaplan-Meier Estimate | 14 | 2024 | 1005 | 0.350 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 332 | 0.350 |
Why?
|
| Cardiovascular Infections | 3 | 2024 | 7 | 0.350 |
Why?
|
| Length of Stay | 13 | 2024 | 1284 | 0.340 |
Why?
|
| Defibrillators, Implantable | 4 | 2007 | 192 | 0.340 |
Why?
|
| Propensity Score | 5 | 2024 | 207 | 0.330 |
Why?
|
| Predictive Value of Tests | 9 | 2024 | 2113 | 0.330 |
Why?
|
| Cooperative Behavior | 2 | 2021 | 217 | 0.330 |
Why?
|
| American Heart Association | 6 | 2023 | 295 | 0.330 |
Why?
|
| Mentors | 2 | 2021 | 145 | 0.330 |
Why?
|
| Electrodes, Implanted | 2 | 2006 | 162 | 0.320 |
Why?
|
| Age Factors | 13 | 2020 | 2802 | 0.320 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 113 | 0.320 |
Why?
|
| Aorta | 5 | 2018 | 541 | 0.310 |
Why?
|
| Adaptation, Physiological | 2 | 2011 | 261 | 0.310 |
Why?
|
| Pacemaker, Artificial | 4 | 2013 | 172 | 0.310 |
Why?
|
| Stroke Volume | 6 | 2021 | 445 | 0.310 |
Why?
|
| Myocardial Infarction | 5 | 2023 | 1000 | 0.310 |
Why?
|
| Systole | 8 | 1999 | 196 | 0.300 |
Why?
|
| Acute Disease | 7 | 2021 | 1093 | 0.300 |
Why?
|
| Chordae Tendineae | 3 | 1999 | 7 | 0.300 |
Why?
|
| Diffusion of Innovation | 3 | 2017 | 97 | 0.290 |
Why?
|
| Delphi Technique | 3 | 2024 | 202 | 0.290 |
Why?
|
| Single Photon Emission Computed Tomography Computed Tomography | 2 | 2024 | 7 | 0.290 |
Why?
|
| Animals | 34 | 2020 | 33765 | 0.290 |
Why?
|
| Recurrence | 11 | 2020 | 1423 | 0.280 |
Why?
|
| Calcium | 1 | 2012 | 1096 | 0.280 |
Why?
|
| Hand | 2 | 2023 | 102 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 1262 | 0.270 |
Why?
|
| Hospital Mortality | 6 | 2020 | 1009 | 0.270 |
Why?
|
| Tourniquets | 2 | 2004 | 10 | 0.270 |
Why?
|
| Quality of Life | 3 | 2006 | 1929 | 0.270 |
Why?
|
| Pulmonary Artery | 6 | 2011 | 439 | 0.270 |
Why?
|
| Disease Models, Animal | 7 | 2015 | 4273 | 0.260 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2021 | 621 | 0.260 |
Why?
|
| Heart Valves | 2 | 2018 | 51 | 0.260 |
Why?
|
| Leukocytes | 2 | 2024 | 207 | 0.260 |
Why?
|
| Body Size | 1 | 2006 | 53 | 0.260 |
Why?
|
| Angiography | 3 | 2018 | 215 | 0.250 |
Why?
|
| Cardiomyopathies | 2 | 2021 | 478 | 0.250 |
Why?
|
| Evidence-Based Medicine | 6 | 2016 | 622 | 0.240 |
Why?
|
| Echocardiography | 8 | 2020 | 1049 | 0.240 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2015 | 359 | 0.240 |
Why?
|
| Diathermy | 1 | 2004 | 4 | 0.240 |
Why?
|
| Paresthesia | 1 | 2004 | 7 | 0.240 |
Why?
|
| Radial Neuropathy | 1 | 2004 | 2 | 0.240 |
Why?
|
| Median Nerve | 1 | 2004 | 15 | 0.240 |
Why?
|
| Catheterization, Peripheral | 3 | 2015 | 126 | 0.240 |
Why?
|
| Hypesthesia | 1 | 2004 | 10 | 0.240 |
Why?
|
| Perfusion | 3 | 2015 | 197 | 0.230 |
Why?
|
| Prosthesis Design | 9 | 2024 | 672 | 0.230 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 40 | 0.230 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 1591 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 826 | 0.220 |
Why?
|
| Enoxaparin | 2 | 2005 | 42 | 0.220 |
Why?
|
| Logistic Models | 11 | 2024 | 1793 | 0.220 |
Why?
|
| Streptococcus mitis | 1 | 2003 | 1 | 0.220 |
Why?
|
| Streptococcus sanguis | 1 | 2003 | 2 | 0.220 |
Why?
|
| Postoperative Hemorrhage | 2 | 2005 | 86 | 0.210 |
Why?
|
| Chi-Square Distribution | 6 | 2015 | 586 | 0.210 |
Why?
|
| Diagnostic Imaging | 4 | 2018 | 271 | 0.210 |
Why?
|
| Anastomosis, Surgical | 5 | 2023 | 169 | 0.210 |
Why?
|
| Shock, Cardiogenic | 2 | 2021 | 187 | 0.210 |
Why?
|
| Machine Learning | 2 | 2022 | 219 | 0.210 |
Why?
|
| Heart Rate | 5 | 2020 | 586 | 0.210 |
Why?
|
| Cause of Death | 4 | 2016 | 459 | 0.210 |
Why?
|
| Blood Coagulation | 2 | 2023 | 118 | 0.210 |
Why?
|
| Interleukin-1 | 3 | 2000 | 143 | 0.210 |
Why?
|
| Chronic Disease | 4 | 2024 | 1168 | 0.200 |
Why?
|
| I-kappa B Proteins | 2 | 2000 | 41 | 0.200 |
Why?
|
| Atrial Function, Left | 4 | 2020 | 27 | 0.200 |
Why?
|
| Catheterization | 3 | 2021 | 235 | 0.200 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2012 | 19 | 0.200 |
Why?
|
| Pericardium | 1 | 2002 | 82 | 0.200 |
Why?
|
| Cultural Diversity | 1 | 2022 | 63 | 0.190 |
Why?
|
| Medicine | 1 | 2023 | 97 | 0.190 |
Why?
|
| Angina Pectoris | 1 | 2002 | 57 | 0.190 |
Why?
|
| Leadership | 2 | 2021 | 230 | 0.190 |
Why?
|
| Secondary Prevention | 1 | 2023 | 212 | 0.190 |
Why?
|
| Ischemia | 3 | 2017 | 344 | 0.190 |
Why?
|
| Preoperative Care | 3 | 2020 | 350 | 0.190 |
Why?
|
| Anger | 1 | 2021 | 30 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2024 | 2059 | 0.190 |
Why?
|
| Graft Rejection | 3 | 2020 | 582 | 0.180 |
Why?
|
| Proportional Hazards Models | 8 | 2020 | 1306 | 0.180 |
Why?
|
| Administration, Oral | 1 | 2023 | 670 | 0.180 |
Why?
|
| Incidence | 9 | 2023 | 3048 | 0.180 |
Why?
|
| Child Advocacy | 1 | 2000 | 8 | 0.180 |
Why?
|
| Bronchial Fistula | 1 | 2020 | 22 | 0.180 |
Why?
|
| Creatinine | 1 | 2022 | 380 | 0.180 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2021 | 42 | 0.180 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 12 | 0.180 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2013 | 114 | 0.180 |
Why?
|
| Blood Transfusion | 1 | 2022 | 301 | 0.180 |
Why?
|
| Vascular Fistula | 1 | 2020 | 30 | 0.180 |
Why?
|
| Surge Capacity | 1 | 2020 | 9 | 0.180 |
Why?
|
| Streptococcal Infections | 1 | 2003 | 244 | 0.170 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2015 | 274 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2024 | 485 | 0.170 |
Why?
|
| Women | 1 | 2020 | 15 | 0.170 |
Why?
|
| Femoral Artery | 3 | 2015 | 190 | 0.170 |
Why?
|
| NF-kappa B | 2 | 2000 | 455 | 0.170 |
Why?
|
| Cardiopulmonary Bypass | 7 | 2015 | 343 | 0.170 |
Why?
|
| Education, Medical | 2 | 2014 | 285 | 0.170 |
Why?
|
| Betacoronavirus | 2 | 2020 | 288 | 0.170 |
Why?
|
| Vascular Patency | 4 | 2012 | 203 | 0.170 |
Why?
|
| Heart Septum | 2 | 1997 | 55 | 0.170 |
Why?
|
| Hospital Costs | 1 | 2021 | 178 | 0.170 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1999 | 19 | 0.160 |
Why?
|
| Antifibrinolytic Agents | 1 | 1999 | 33 | 0.160 |
Why?
|
| Tyrosine | 1 | 1999 | 152 | 0.160 |
Why?
|
| Chondroitin Sulfates | 2 | 2014 | 14 | 0.160 |
Why?
|
| Lidocaine | 1 | 1999 | 48 | 0.160 |
Why?
|
| Analgesia, Epidural | 1 | 1999 | 27 | 0.160 |
Why?
|
| Complement C3 | 1 | 1999 | 47 | 0.160 |
Why?
|
| Analysis of Variance | 5 | 2012 | 1008 | 0.160 |
Why?
|
| Morphine | 1 | 1999 | 87 | 0.160 |
Why?
|
| Time Perception | 1 | 2018 | 11 | 0.160 |
Why?
|
| Blood Pressure | 5 | 2012 | 1325 | 0.160 |
Why?
|
| Self Concept | 1 | 2020 | 157 | 0.160 |
Why?
|
| Thoracic Injuries | 1 | 1999 | 91 | 0.160 |
Why?
|
| Medical Errors | 1 | 2020 | 155 | 0.150 |
Why?
|
| Suture Techniques | 3 | 2018 | 198 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 651 | 0.150 |
Why?
|
| Hypoxia | 1 | 2020 | 247 | 0.150 |
Why?
|
| Probability | 6 | 2009 | 321 | 0.150 |
Why?
|
| Constriction | 4 | 2015 | 49 | 0.150 |
Why?
|
| Algorithms | 4 | 2024 | 1593 | 0.150 |
Why?
|
| Tomography | 1 | 2018 | 41 | 0.150 |
Why?
|
| Heart Conduction System | 1 | 2019 | 145 | 0.150 |
Why?
|
| Lung Diseases | 3 | 2015 | 385 | 0.150 |
Why?
|
| Surface-Active Agents | 1 | 2018 | 31 | 0.150 |
Why?
|
| Analgesics, Opioid | 2 | 1999 | 402 | 0.150 |
Why?
|
| Anesthesiologists | 1 | 2018 | 36 | 0.150 |
Why?
|
| Heparin | 3 | 2014 | 227 | 0.150 |
Why?
|
| Staphylococcal Infections | 1 | 2003 | 553 | 0.150 |
Why?
|
| Transposition of Great Vessels | 1 | 2019 | 132 | 0.150 |
Why?
|
| Hemoglobins | 1 | 2019 | 301 | 0.150 |
Why?
|
| Compliance | 2 | 2009 | 17 | 0.140 |
Why?
|
| Ethics, Medical | 1 | 2000 | 395 | 0.140 |
Why?
|
| Hemostatics | 1 | 2018 | 57 | 0.140 |
Why?
|
| Progesterone | 1 | 2020 | 624 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2017 | 58 | 0.140 |
Why?
|
| Prognosis | 3 | 2024 | 4514 | 0.140 |
Why?
|
| Oxygen | 2 | 2012 | 547 | 0.140 |
Why?
|
| Students, Medical | 1 | 2022 | 361 | 0.140 |
Why?
|
| Calcinosis | 1 | 1998 | 170 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 146 | 0.140 |
Why?
|
| Abdomen | 1 | 2017 | 130 | 0.140 |
Why?
|
| Cardiac Care Facilities | 1 | 2016 | 8 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 288 | 0.140 |
Why?
|
| Smoking Prevention | 1 | 2016 | 37 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 596 | 0.140 |
Why?
|
| Acidosis | 1 | 2017 | 93 | 0.140 |
Why?
|
| Comorbidity | 5 | 2015 | 1496 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 217 | 0.130 |
Why?
|
| Animals, Newborn | 1 | 2020 | 991 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 796 | 0.130 |
Why?
|
| Magnesium | 1 | 2016 | 121 | 0.130 |
Why?
|
| Aorta, Abdominal | 1 | 1997 | 120 | 0.130 |
Why?
|
| Ontario | 1 | 2016 | 66 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 865 | 0.130 |
Why?
|
| Medical Staff Privileges | 5 | 2014 | 9 | 0.130 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 13 | 0.130 |
Why?
|
| Pain | 1 | 1999 | 470 | 0.130 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2016 | 37 | 0.130 |
Why?
|
| Competitive Behavior | 1 | 2015 | 10 | 0.130 |
Why?
|
| Elasticity | 3 | 2005 | 92 | 0.130 |
Why?
|
| Health Personnel | 1 | 2020 | 499 | 0.130 |
Why?
|
| Pneumonectomy | 1 | 2016 | 129 | 0.120 |
Why?
|
| Diastole | 7 | 1997 | 169 | 0.120 |
Why?
|
| Potassium | 1 | 2016 | 279 | 0.120 |
Why?
|
| Ablation Techniques | 1 | 2015 | 31 | 0.120 |
Why?
|
| Disease Progression | 4 | 2020 | 2025 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2019 | 1388 | 0.120 |
Why?
|
| Stress, Mechanical | 4 | 2011 | 170 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3249 | 0.120 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2015 | 18 | 0.120 |
Why?
|
| Sex Factors | 5 | 2024 | 1260 | 0.120 |
Why?
|
| Delirium | 1 | 2015 | 47 | 0.120 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2007 | 39 | 0.120 |
Why?
|
| Sheep | 4 | 2004 | 208 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 194 | 0.120 |
Why?
|
| Smoking Cessation | 1 | 2016 | 196 | 0.120 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2015 | 39 | 0.120 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2015 | 40 | 0.120 |
Why?
|
| Tissue Preservation | 1 | 1994 | 15 | 0.120 |
Why?
|
| Accreditation | 1 | 2015 | 81 | 0.120 |
Why?
|
| Drug Contamination | 1 | 2014 | 36 | 0.120 |
Why?
|
| Myocardium | 2 | 2019 | 984 | 0.120 |
Why?
|
| Renal Dialysis | 2 | 2018 | 842 | 0.120 |
Why?
|
| Prospective Studies | 11 | 2015 | 6040 | 0.110 |
Why?
|
| Genetic Testing | 1 | 2000 | 997 | 0.110 |
Why?
|
| Health Facilities | 1 | 2014 | 59 | 0.110 |
Why?
|
| Teaching | 1 | 2015 | 183 | 0.110 |
Why?
|
| Coronary Angiography | 3 | 2013 | 417 | 0.110 |
Why?
|
| Adolescent | 10 | 2018 | 19112 | 0.110 |
Why?
|
| Electrocardiography | 6 | 2019 | 958 | 0.110 |
Why?
|
| Rats | 1 | 2020 | 3653 | 0.110 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 171 | 0.110 |
Why?
|
| Anti-Arrhythmia Agents | 5 | 2017 | 218 | 0.110 |
Why?
|
| Paraplegia | 2 | 2024 | 91 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2015 | 258 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 964 | 0.110 |
Why?
|
| Multimodal Imaging | 2 | 2024 | 111 | 0.110 |
Why?
|
| Lung | 2 | 2023 | 1476 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 468 | 0.100 |
Why?
|
| Coronary Restenosis | 1 | 2012 | 20 | 0.100 |
Why?
|
| Models, Cardiovascular | 4 | 2015 | 180 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2016 | 472 | 0.100 |
Why?
|
| Monocrotaline | 1 | 2012 | 3 | 0.100 |
Why?
|
| Transplantation, Homologous | 3 | 2006 | 659 | 0.100 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 37 | 0.100 |
Why?
|
| Ischemic Attack, Transient | 1 | 2012 | 55 | 0.100 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2015 | 41 | 0.100 |
Why?
|
| Knowledge Bases | 4 | 2012 | 36 | 0.100 |
Why?
|
| Heart Arrest, Induced | 2 | 2002 | 73 | 0.100 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2011 | 11 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2012 | 84 | 0.100 |
Why?
|
| Esophagectomy | 1 | 1992 | 60 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2011 | 117 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 3 | 2003 | 443 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2000 | 2050 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2015 | 747 | 0.090 |
Why?
|
| Warfarin | 1 | 2012 | 118 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 507 | 0.090 |
Why?
|
| Heart Neoplasms | 1 | 2012 | 100 | 0.090 |
Why?
|
| Smoking | 1 | 2016 | 1031 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2012 | 369 | 0.090 |
Why?
|
| Nervous System Diseases | 2 | 2007 | 372 | 0.090 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 450 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 196 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2014 | 529 | 0.090 |
Why?
|
| Sufentanil | 2 | 2001 | 4 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 327 | 0.090 |
Why?
|
| Biomechanical Phenomena | 1 | 2011 | 246 | 0.090 |
Why?
|
| Brain | 1 | 2002 | 2964 | 0.090 |
Why?
|
| Equipment Design | 3 | 2007 | 601 | 0.090 |
Why?
|
| Anesthetics, Intravenous | 2 | 2001 | 47 | 0.090 |
Why?
|
| Cohort Studies | 6 | 2020 | 4710 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 713 | 0.080 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 2017 | 60 | 0.080 |
Why?
|
| Intestinal Mucosa | 3 | 2000 | 773 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2003 | 238 | 0.080 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2003 | 95 | 0.080 |
Why?
|
| Pulmonary Veins | 3 | 2008 | 162 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2009 | 74 | 0.080 |
Why?
|
| Elective Surgical Procedures | 2 | 2010 | 158 | 0.080 |
Why?
|
| Electric Countershock | 2 | 2007 | 67 | 0.080 |
Why?
|
| Educational Status | 2 | 2024 | 270 | 0.080 |
Why?
|
| Prosthesis Fitting | 1 | 2008 | 7 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 2758 | 0.080 |
Why?
|
| Quality of Health Care | 4 | 2012 | 391 | 0.080 |
Why?
|
| Atrial Function | 1 | 2008 | 12 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2015 | 3546 | 0.080 |
Why?
|
| Tricuspid Valve | 1 | 2009 | 59 | 0.080 |
Why?
|
| Pressure | 3 | 2005 | 130 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2019 | 147 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2020 | 1168 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 1992 | 359 | 0.070 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2005 | 42 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2011 | 771 | 0.070 |
Why?
|
| Hematologic Agents | 1 | 2007 | 6 | 0.070 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 73 | 0.070 |
Why?
|
| Swine | 5 | 2015 | 1155 | 0.070 |
Why?
|
| Aortography | 3 | 2010 | 200 | 0.070 |
Why?
|
| Pericardiectomy | 2 | 2008 | 9 | 0.070 |
Why?
|
| Factor VIIa | 1 | 2007 | 24 | 0.070 |
Why?
|
| Risk | 2 | 2016 | 747 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 159 | 0.070 |
Why?
|
| Young Adult | 6 | 2018 | 8865 | 0.070 |
Why?
|
| Pericardial Effusion | 1 | 2007 | 64 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2015 | 861 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2000 | 993 | 0.070 |
Why?
|
| Thoracic Arteries | 1 | 2006 | 5 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 866 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2007 | 93 | 0.070 |
Why?
|
| Time | 2 | 2017 | 94 | 0.070 |
Why?
|
| Arteriovenous Fistula | 1 | 2006 | 56 | 0.060 |
Why?
|
| Angina, Unstable | 2 | 2003 | 52 | 0.060 |
Why?
|
| Ligation | 1 | 2005 | 132 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1878 | 0.060 |
Why?
|
| Leiomyosarcoma | 1 | 2004 | 29 | 0.060 |
Why?
|
| Heart-Lung Transplantation | 2 | 2001 | 23 | 0.060 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2024 | 7 | 0.060 |
Why?
|
| Ultrasonics | 1 | 2004 | 36 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2004 | 66 | 0.060 |
Why?
|
| Thumb | 1 | 2004 | 29 | 0.060 |
Why?
|
| Treatment Failure | 3 | 2016 | 338 | 0.060 |
Why?
|
| Waiting Lists | 2 | 2021 | 225 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2007 | 296 | 0.060 |
Why?
|
| Prevalence | 2 | 2013 | 2406 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2015 | 940 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 105 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2007 | 459 | 0.060 |
Why?
|
| Axillary Artery | 1 | 2003 | 27 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 2004 | 139 | 0.060 |
Why?
|
| Cross Infection | 1 | 2007 | 331 | 0.060 |
Why?
|
| Spirometry | 1 | 2023 | 74 | 0.050 |
Why?
|
| Motion | 1 | 2023 | 44 | 0.050 |
Why?
|
| DNA Glycosylases | 1 | 2003 | 32 | 0.050 |
Why?
|
| Natriuretic Agents | 1 | 2003 | 31 | 0.050 |
Why?
|
| Income | 1 | 2024 | 133 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2004 | 360 | 0.050 |
Why?
|
| Forced Expiratory Volume | 1 | 2023 | 169 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2003 | 70 | 0.050 |
Why?
|
| Aneurysm, False | 1 | 2004 | 102 | 0.050 |
Why?
|
| Clinical Protocols | 2 | 2014 | 235 | 0.050 |
Why?
|
| Thiocarbamates | 2 | 2000 | 5 | 0.050 |
Why?
|
| Survivors | 1 | 2005 | 345 | 0.050 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2000 | 34 | 0.050 |
Why?
|
| Pyrrolidines | 2 | 2000 | 36 | 0.050 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2004 | 209 | 0.050 |
Why?
|
| Kidney | 2 | 2006 | 1337 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 174 | 0.050 |
Why?
|
| Electrodes | 1 | 2002 | 97 | 0.050 |
Why?
|
| Data Collection | 2 | 2021 | 386 | 0.050 |
Why?
|
| Oxygenators | 1 | 2001 | 3 | 0.050 |
Why?
|
| Caco-2 Cells | 2 | 1999 | 96 | 0.050 |
Why?
|
| Personality | 1 | 2023 | 101 | 0.050 |
Why?
|
| Heart Bypass, Left | 1 | 2001 | 15 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2006 | 644 | 0.050 |
Why?
|
| Muromonab-CD3 | 1 | 2001 | 8 | 0.050 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 127 | 0.050 |
Why?
|
| Leg | 2 | 2003 | 155 | 0.050 |
Why?
|
| Decontamination | 1 | 2021 | 12 | 0.050 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2001 | 39 | 0.050 |
Why?
|
| Antilymphocyte Serum | 1 | 2001 | 56 | 0.050 |
Why?
|
| Intensive Care Units | 2 | 2015 | 483 | 0.050 |
Why?
|
| Students | 1 | 2023 | 251 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 133 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2014 | 1243 | 0.050 |
Why?
|
| Decision Trees | 1 | 2000 | 49 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 628 | 0.040 |
Why?
|
| Ventricular Function | 2 | 1998 | 92 | 0.040 |
Why?
|
| Poverty | 1 | 2024 | 419 | 0.040 |
Why?
|
| Men | 1 | 2020 | 4 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 86 | 0.040 |
Why?
|
| Genetic Carrier Screening | 1 | 2000 | 75 | 0.040 |
Why?
|
| Dermatan Sulfate | 1 | 2000 | 4 | 0.040 |
Why?
|
| Heparitin Sulfate | 1 | 2000 | 20 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 117 | 0.040 |
Why?
|
| Analgesics | 1 | 2021 | 135 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 220 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2012 | 753 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 424 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 99 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 113 | 0.040 |
Why?
|
| Tosyllysine Chloromethyl Ketone | 1 | 1999 | 1 | 0.040 |
Why?
|
| Leupeptins | 1 | 1999 | 26 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 3671 | 0.040 |
Why?
|
| Anesthetics, Combined | 1 | 1999 | 7 | 0.040 |
Why?
|
| Genistein | 1 | 1999 | 39 | 0.040 |
Why?
|
| Dilatation, Pathologic | 3 | 2004 | 93 | 0.040 |
Why?
|
| Antibodies | 1 | 2020 | 369 | 0.040 |
Why?
|
| State Government | 1 | 1999 | 29 | 0.040 |
Why?
|
| Isoflurane | 1 | 1999 | 45 | 0.040 |
Why?
|
| Mammary Arteries | 2 | 2012 | 26 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 3 | 2007 | 2394 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2000 | 184 | 0.040 |
Why?
|
| Respiration | 1 | 1999 | 123 | 0.040 |
Why?
|
| Registries | 2 | 2015 | 1394 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 1998 | 31 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2020 | 176 | 0.040 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2018 | 2 | 0.040 |
Why?
|
| Intermittent Claudication | 1 | 1998 | 54 | 0.040 |
Why?
|
| Hemostasis, Surgical | 1 | 2018 | 37 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 661 | 0.040 |
Why?
|
| Tissue Adhesives | 1 | 2018 | 35 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 54 | 0.040 |
Why?
|
| Health Expenditures | 1 | 1999 | 103 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2012 | 250 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2017 | 59 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2000 | 249 | 0.040 |
Why?
|
| Cytokines | 2 | 2003 | 1285 | 0.040 |
Why?
|
| Thrombosis | 3 | 2000 | 520 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2830 | 0.040 |
Why?
|
| Action Potentials | 1 | 2020 | 501 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 213 | 0.030 |
Why?
|
| Torsion Abnormality | 2 | 1994 | 34 | 0.030 |
Why?
|
| Intersectoral Collaboration | 1 | 2016 | 21 | 0.030 |
Why?
|
| Rheumatic Heart Disease | 1 | 2017 | 37 | 0.030 |
Why?
|
| Transfection | 1 | 1999 | 1068 | 0.030 |
Why?
|
| Infusions, Intravenous | 3 | 2006 | 537 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2000 | 448 | 0.030 |
Why?
|
| Graft Survival | 2 | 2012 | 525 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 197 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1998 | 393 | 0.030 |
Why?
|
| Medicaid | 1 | 1999 | 245 | 0.030 |
Why?
|
| Biomarkers | 2 | 2015 | 2946 | 0.030 |
Why?
|
| Communication | 1 | 2020 | 513 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2000 | 316 | 0.030 |
Why?
|
| Operative Time | 1 | 2016 | 160 | 0.030 |
Why?
|
| Patient Safety | 1 | 2020 | 394 | 0.030 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2015 | 18 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 134 | 0.030 |
Why?
|
| Postoperative Period | 2 | 1994 | 330 | 0.030 |
Why?
|
| Models, Structural | 1 | 1995 | 49 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2015 | 16 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 1999 | 2813 | 0.030 |
Why?
|
| Medicare | 1 | 1999 | 424 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 172 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1239 | 0.030 |
Why?
|
| Iliac Artery | 2 | 2010 | 92 | 0.030 |
Why?
|
| Computer-Assisted Instruction | 1 | 2015 | 51 | 0.030 |
Why?
|
| North America | 1 | 2015 | 239 | 0.030 |
Why?
|
| Polynucleotides | 1 | 1994 | 9 | 0.030 |
Why?
|
| Papillary Muscles | 1 | 1994 | 19 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2015 | 98 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 59 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 2527 | 0.030 |
Why?
|
| Base Sequence | 1 | 1999 | 3093 | 0.030 |
Why?
|
| Methoxamine | 1 | 1994 | 2 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 1994 | 88 | 0.030 |
Why?
|
| Thrombin | 1 | 1994 | 60 | 0.030 |
Why?
|
| Postoperative Care | 2 | 2013 | 295 | 0.030 |
Why?
|
| Hydroxybutyrates | 1 | 1994 | 44 | 0.030 |
Why?
|
| Policy Making | 1 | 2014 | 59 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2000 | 753 | 0.030 |
Why?
|
| Video Recording | 1 | 2015 | 181 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1994 | 29 | 0.030 |
Why?
|
| Polyesters | 1 | 1994 | 40 | 0.030 |
Why?
|
| Dobutamine | 1 | 1994 | 55 | 0.030 |
Why?
|
| Normal Distribution | 1 | 2013 | 18 | 0.030 |
Why?
|
| Troponin T | 1 | 2015 | 245 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1994 | 95 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2005 | 1806 | 0.030 |
Why?
|
| Program Development | 1 | 2014 | 190 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2016 | 375 | 0.030 |
Why?
|
| Contrast Media | 1 | 2016 | 470 | 0.030 |
Why?
|
| Hematoma | 1 | 1993 | 93 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 600 | 0.030 |
Why?
|
| Laryngeal Nerve Injuries | 1 | 1992 | 1 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2016 | 385 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 1994 | 150 | 0.030 |
Why?
|
| Horner Syndrome | 1 | 1992 | 12 | 0.030 |
Why?
|
| Patient Acuity | 1 | 2012 | 63 | 0.030 |
Why?
|
| Echocardiography, Doppler | 2 | 2009 | 170 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 522 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 362 | 0.020 |
Why?
|
| Washington | 1 | 2011 | 33 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2012 | 197 | 0.020 |
Why?
|
| Morbidity | 2 | 2006 | 241 | 0.020 |
Why?
|
| Pediatrics | 1 | 2000 | 1141 | 0.020 |
Why?
|
| Pneumonia | 1 | 2014 | 325 | 0.020 |
Why?
|
| Models, Theoretical | 2 | 2008 | 356 | 0.020 |
Why?
|
| Reference Values | 2 | 2007 | 697 | 0.020 |
Why?
|
| Endoleak | 1 | 2010 | 43 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2013 | 377 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 1386 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 736 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2014 | 340 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2226 | 0.020 |
Why?
|
| Child | 2 | 2018 | 24241 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 1992 | 1213 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 451 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 16 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 279 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2006 | 73 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 294 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 410 | 0.020 |
Why?
|
| Linear Models | 1 | 2007 | 669 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2006 | 87 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2007 | 164 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 1695 | 0.020 |
Why?
|
| Mutation | 1 | 1999 | 5775 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2005 | 23 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 133 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2004 | 103 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2007 | 434 | 0.010 |
Why?
|
| Remission Induction | 1 | 2004 | 300 | 0.010 |
Why?
|
| Lymphotoxin-beta | 1 | 2003 | 1 | 0.010 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2003 | 5 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 8 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 356 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2003 | 14 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2026 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 63 | 0.010 |
Why?
|
| Central Venous Pressure | 1 | 2003 | 25 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2003 | 107 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7161 | 0.010 |
Why?
|
| Natriuresis | 1 | 2003 | 37 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 1151 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2003 | 28 | 0.010 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2003 | 28 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 1682 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2005 | 257 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 685 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 462 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2003 | 189 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 160 | 0.010 |
Why?
|
| Vasodilation | 1 | 2003 | 191 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 224 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2003 | 231 | 0.010 |
Why?
|
| Preanesthetic Medication | 1 | 2001 | 3 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 1068 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 330 | 0.010 |
Why?
|
| Hypotension | 1 | 2003 | 177 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2001 | 297 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 325 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1292 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 709 | 0.010 |
Why?
|
| Suppuration | 1 | 2000 | 3 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2000 | 18 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 1012 | 0.010 |
Why?
|
| Oxidants | 1 | 2000 | 25 | 0.010 |
Why?
|
| Bronchiectasis | 1 | 2000 | 23 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2000 | 49 | 0.010 |
Why?
|
| Demography | 1 | 2000 | 239 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2000 | 175 | 0.010 |
Why?
|
| Accounting | 1 | 1999 | 3 | 0.010 |
Why?
|
| Population Density | 1 | 1999 | 33 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2000 | 270 | 0.010 |
Why?
|
| Pulse | 1 | 1998 | 31 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1998 | 17 | 0.010 |
Why?
|
| Anesthetics, Inhalation | 1 | 1999 | 46 | 0.010 |
Why?
|
| Endarterectomy | 1 | 1998 | 22 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 1998 | 53 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1998 | 68 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1998 | 97 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 1061 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 1998 | 80 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1998 | 136 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 228 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 1999 | 121 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 807 | 0.010 |
Why?
|
| Health Services Research | 1 | 1999 | 186 | 0.010 |
Why?
|
| Antioxidants | 1 | 2000 | 338 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 675 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2000 | 257 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 245 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1998 | 966 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1998 | 151 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 1682 | 0.010 |
Why?
|
| Blood Volume | 1 | 1996 | 80 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1529 | 0.010 |
Why?
|
| Transportation of Patients | 1 | 1996 | 55 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1998 | 496 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1999 | 1590 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1994 | 36 | 0.010 |
Why?
|
| Aptamers, Nucleotide | 1 | 1994 | 24 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 1585 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1994 | 153 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1999 | 863 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 338 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 1994 | 123 | 0.010 |
Why?
|
| Consciousness | 1 | 1993 | 49 | 0.010 |
Why?
|
| Collagen | 1 | 1994 | 315 | 0.010 |
Why?
|
| Cattle | 1 | 1993 | 559 | 0.010 |
Why?
|
| Random Allocation | 1 | 1993 | 427 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1994 | 514 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1993 | 398 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2000 | 2585 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 1996 | 1070 | 0.000 |
Why?
|